Chief Executive Officer

Danisco buy-out fails to dent DuPont Q2 earnings

Danisco buy-out fails to dent DuPont Q2 earnings

By Shane Starling

Dupont, which earlier in the year warned that its May $6.49bn acquisition of Danisco would dent its yearly profits, has defied expectations in second quarter results published today.

April 2011 in pictures: Twinlab, gut health & Japan

April 2011 in pictures: Twinlab, gut health & Japan

By Stephen Daniells

As April draws to a close we look back at a month of news, which saw Twinlab appoint a new chief executive, FTC crack down on bogus acai-weight loss claims, and a breakthrough in gut health understanding.

Naturex set for “one or two” acquisitions in 2011: President

Naturex set for “one or two” acquisitions in 2011: President

By Shane Starling

Naturex will expand again in 2011 with several “€5-20m” targets, 1.5 years after completing the €110m integration of Spanish supplier Natraceutical that made the French botanical extracts supplier the biggest in the world.

Pontakios: Irradiation problems despite GMP crackdown

Dispatches from SupplySide West

Price drives ongoing illegal irradiation practices

By Shane Starling

Irradiation has risen in importance as it has become specifically outlawed in new Good Manufacturing Practice (GMP) regulations. But the practice continues due to its ability to cheaply remove contaminants from raw materials.

Robinson Pharma joins CRN

Robinson Pharma joins CRN

Californian-based Robinson Pharma Inc. has joined the Council for Responsible Nutrition (CRN) as a full voting member, a move it said reflects its desire to contribute to the overall well-being of the industry.

The devil in GMP details

DSHEA turns 15

The devil in GMP details

By Shane Starling

In the fifth and final installment of this DSHEA special, Frank Jaksch, the president and chief executive officer of Californian-based botanicals reference provider, Chromadex, outlines why he thinks current GMP inspection methodologies are unlikely to...

Too many trade groups spoil the lobbying broth?

Special edition: DSHEA turns 15

Too many trade groups spoil the lobbying broth?

By Shane Starling

In the third part of this DSHEA special, George Pontiakos, the president and chief executive officer of California-based, BI Nutraceuticals, tells Shane Starling why the dietary supplements industry suffers under the lack of a unified voice.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers